We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CU6.AU

Price
1.52
Stock movement down
-0.16 (-9.52%)
Company name
Clarity Pharmaceuticals Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
487.38M
Ent value
447.81M
Price/Sales
42.36
Price/Book
3.33
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-45.71%
3 year return
37.48%
5 year return
-
10 year return
-
Last updated: 2025-04-08

DIVIDENDS

CU6.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales42.36
Price to Book3.33
EV to Sales38.92

FINANCIALS

Per share

Per share data
Current share count320.64M
EPS (TTM)-0.18
FCF per share (TTM)-0.20

Income statement

Income statement data
Revenue (TTM)11.51M
Gross profit (TTM)11.46M
Operating income (TTM)-59.32M
Net income (TTM)-50.93M
EPS (TTM)-0.18
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)99.56%
Operating margin (TTM)-515.51%
Profit margin (TTM)-442.58%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash47.90M
Net receivables12.63M
Total current assets154.06M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets154.63M
Accounts payable2.08M
Short/Current long term debt0.00
Total current liabilities8.09M
Total liabilities8.33M
Shareholder's equity146.30M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-56.59M
Capital expenditures (TTM)724.63K
Free cash flow (TTM)-57.31M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-34.81%
Return on Assets-32.93%
Return on Invested Capital-34.81%
Cash Return on Invested Capital-39.17%

STOCK INFORMATION

Stock chart

Stock price data
Open1.50
Daily high1.56
Daily low1.47
Daily Volume7.31M
All-time high8.79
1y analyst estimate8.87
Beta1.68
EPS (TTM)-0.18
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
CU6.AUS&P500
Current price drop from All-time high-82.71%-17.71%
Highest price drop-82.71%-56.47%
Date of highest drop7 Apr 20259 Mar 2009
Avg drop from high-35.02%-11.07%
Avg time to new high16 days12 days
Max time to new high574 days1805 days
COMPANY DETAILS
CU6.AU (Clarity Pharmaceuticals Ltd) company logo
Marketcap
487.38M
Marketcap category
Small-cap
Description
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States. The company's products include SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2; developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. It develops theranostic therapy and imaging products for the treatment of cancer in children and adults. The company was incorporated in 2010 and is based in Sydney, Australia.
Employees
50
Website
https://www.claritypharmaceuticals.com
Investor relations
-
SEC filings
CU6.AU SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved